VeraCyte Obtains $10,500,000 New Financing Round

  • Feed Type
  • Date
    9/30/2009
  • Company Name
    VeraCyte
  • Mailing Address
    Undisclosed South San Francisco, CA 94080
  • Company Description
    Operates as an early stage cancer diagnostics company.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    TPG – Texas Pacific Group Ventures
  • Venture Investor
    Versant Ventures
  • Venture Investor
    Undisclosed

Trending on Xconomy